Culinary Art Cover Letter Sample

few thousand euros in millions.


I invest in stock market is a hoax, a scam devised by the bankers. "Give me your money I choose what suits you." The height of the scam have been the funds. Why Warren Buffet recommends small companies for the small investor? Because you can learn more. Because they have more potential. But above all, because he can choose! Investing in small companies with high growth potential has risks. But it has the advantage that a single winner can compensate for many losses. And finding a winner is a fascinating sport. The game is to transform a few thousand euros in millions in a period of 15 or 20 years. If you invest in 4 or 5 of those companies, no matter who fail two or three. The remaining offset these losses and ensure you a millionaire retirement. Of course the risk is not even a hit. That is what we must try to avoid. And in any case that is what would happen to the Investment Fund that was going to sell the bank, that would be correct not a single one. Worse will not do and you save the commissions. How to choose a company with growth potential? I'm going to contradict my friend The Braying , which owns shares in Pfizer. The time to invest in Pfizer was in 1985 . Not anymore. For many who discover miracle drugs, their growth is limited. The same is true of younger companies like Genentech. A careful investor would have invested in Genentech in 1990. But it is not the time to invest in Genentech, if we want to multiply our earnings over a hundred . The same is true of companies like Ford. Good time to invest in Ford was when they began to produce a luxury item, like cars, for the middle class. Model T. That had the capacity to grow. Now, with a market saturated with supply, in a mature industry, fighting for lower costs, and is not the time to invest in Ford. What then invest? That is the question whose answer differentiates a successful investor of another. This is not play the lottery and see if we succeed by chance. Can the hydrogen the replacement of oil? Do we invest in companies involved in that? Or renewable energy? Or in the mobile Internet? Or in biotechnology? We talked the other day RNAi . certainly one of my choices as a technology of the future is RNAi. What's yours? You can leave a message if you want to share which you think is the company or industry in the future. Do not fall for the scam bank to "invest in the stock market." It is good business to invest in good industries. Invest in good companies when they are taking, and taking advantage (or about to take advantage) to their best ideas! Investing in shares, not stock.

Culinary Art Cover Letter Sample

few thousand euros in millions.


I invest in stock market is a hoax, a scam devised by the bankers. "Give me your money I choose what suits you." The height of the scam have been the funds. Why Warren Buffet recommends small companies for the small investor? Because you can learn more. Because they have more potential. But above all, because he can choose! Investing in small companies with high growth potential has risks. But it has the advantage that a single winner can compensate for many losses. And finding a winner is a fascinating sport. The game is to transform a few thousand euros in millions in a period of 15 or 20 years. If you invest in 4 or 5 of those companies, no matter who fail two or three. The remaining offset these losses and ensure you a millionaire retirement. Of course the risk is not even a hit. That is what we must try to avoid. And in any case that is what would happen to the Investment Fund that was going to sell the bank, that would be correct not a single one. Worse will not do and you save the commissions. How to choose a company with growth potential? I'm going to contradict my friend The Braying , which owns shares in Pfizer. The time to invest in Pfizer was in 1985 . Not anymore. For many who discover miracle drugs, their growth is limited. The same is true of younger companies like Genentech. A careful investor would have invested in Genentech in 1990. But it is not the time to invest in Genentech, if we want to multiply our earnings over a hundred . The same is true of companies like Ford. Good time to invest in Ford was when they began to produce a luxury item, like cars, for the middle class. Model T. That had the capacity to grow. Now, with a market saturated with supply, in a mature industry, fighting for lower costs, and is not the time to invest in Ford. What then invest? That is the question whose answer differentiates a successful investor of another. This is not play the lottery and see if we succeed by chance. Can the hydrogen the replacement of oil? Do we invest in companies involved in that? Or renewable energy? Or in the mobile Internet? Or in biotechnology? We talked the other day RNAi . certainly one of my choices as a technology of the future is RNAi. What's yours? You can leave a message if you want to share which you think is the company or industry in the future. Do not fall for the scam bank to "invest in the stock market." It is good business to invest in good industries. Invest in good companies when they are taking, and taking advantage (or about to take advantage) to their best ideas! Investing in shares, not stock.

Core Skateboard Trucks

technology that can change the pharmaceutical industry: the RNA interference



traditional pharmaceutical industry is based on a simple principle: to discover the so-called "magic bullets" that can cure disease or relieve symptoms. For years it was a search industry by trial and error: a chemical is tested to see if it worked. If you did not work, try the following. Many of these compounds were artificial dyes, drugs or natural compounds and plant extracts. drugs were sought blindly. This paradigm quite primitive monopolized medicine until the invention of biotechnology, with the founding of the first company Biotechnology: Genentech. Investors in Genentech are rich today, multiplying your investment by 100 in 15 years , so that today would be 10mil euros one million euros. The idea of \u200b\u200bGenentech and other Biotechs early as Amgen, was to take human proteins, whose function was known, produced industrially and used as drugs. The patient was cured with substances that were not artificial, and dyes, or exogenous, such as plant extracts, but with substances produced by the human body and in which the patient was deficient. The first medicines were based on growth hormone, insulin or interferon, and antibodies to other proteins. It had the advantage that would not be so blindly. why biotechnology has saved many lives and become billionaires many investors. But biotechnology has a limitation: only proteins could act outside of cells, primarily in the bloodstream. entry and manipulation within the cells was forbidden territory. But the Nobel Prize for medicine this year honors the discovery that may forever change the treatment of disease. After many years, there is finally something to get excited about back in business pharmacist: RNA interference or RNAi. Two companies are the most important patents for this process: Sirna Therapeutics and Alnylam Pharmaceuticals . Both have increased their price by four in the last two or three years. And big companies have realized they are at risk of being left out of a total revolution that potentially encompasses the best of both worlds: able to develop as drugs, without going blind, as in classical biotechnology, but also access all corners of the human body, not just the blood, as in the pharmacy of the classic "magic bullets." Merck has been the first to react. Just make an offer for Sirna Therapeutics for more than one billion dollars. If there is a bidding war by siRNA, Merck opar one of the companies. Alnylam is only , which for many is even better company than siRNA. How may pay by Alnylam? Think it's scary, but the scariest thought may be worth as Alnylam if not sold and becomes the new Genentech of Biotechs 2.0 ... Alnylam Could be the Google of the pharmacy, the absolute ruler?

Disclosure: I have had shares of both companies in the past and still hold shares of Alnylam, as mentioned in a previous post.

Core Skateboard Trucks

technology that can change the pharmaceutical industry: the RNA interference



traditional pharmaceutical industry is based on a simple principle: to discover the so-called "magic bullets" that can cure disease or relieve symptoms. For years it was a search industry by trial and error: a chemical is tested to see if it worked. If you did not work, try the following. Many of these compounds were artificial dyes, drugs or natural compounds and plant extracts. drugs were sought blindly. This paradigm quite primitive monopolized medicine until the invention of biotechnology, with the founding of the first company Biotechnology: Genentech. Investors in Genentech are rich today, multiplying your investment by 100 in 15 years , so that today would be 10mil euros one million euros. The idea of \u200b\u200bGenentech and other Biotechs early as Amgen, was to take human proteins, whose function was known, produced industrially and used as drugs. The patient was cured with substances that were not artificial, and dyes, or exogenous, such as plant extracts, but with substances produced by the human body and in which the patient was deficient. The first medicines were based on growth hormone, insulin or interferon, and antibodies to other proteins. It had the advantage that would not be so blindly. why biotechnology has saved many lives and become billionaires many investors. But biotechnology has a limitation: only proteins could act outside of cells, primarily in the bloodstream. entry and manipulation within the cells was forbidden territory. But the Nobel Prize for medicine this year honors the discovery that may forever change the treatment of disease. After many years, there is finally something to get excited about back in business pharmacist: RNA interference or RNAi. Two companies are the most important patents for this process: Sirna Therapeutics and Alnylam Pharmaceuticals . Both have increased their price by four in the last two or three years. And big companies have realized they are at risk of being left out of a total revolution that potentially encompasses the best of both worlds: able to develop as drugs, without going blind, as in classical biotechnology, but also access all corners of the human body, not just the blood, as in the pharmacy of the classic "magic bullets." Merck has been the first to react. Just make an offer for Sirna Therapeutics for more than one billion dollars. If there is a bidding war by siRNA, Merck opar one of the companies. Alnylam is only , which for many is even better company than siRNA. How may pay by Alnylam? Think it's scary, but the scariest thought may be worth as Alnylam if not sold and becomes the new Genentech of Biotechs 2.0 ... Alnylam Could be the Google of the pharmacy, the absolute ruler?

Disclosure: I have had shares of both companies in the past and still hold shares of Alnylam, as mentioned in a previous post.

High Fever Cause Of Gums Wound?

A good year for mushrooms ... at Google



The increase in living standards, and even increased leisure time available, it makes more and more families go into the field to perform the salutary work of collecting mushrooms. not the same for a walk in the field without a definite goal, to go with the firm intention of looking for mushrooms, because mushrooms look brings the excitement built-in "seek and find." Any good fan will have been cuentade that this year has been excellent in mushrooms. Or rovellones chanterelles, porcini mushrooms, blue foot, Lepiotas, Amanita, Coprinus, agarose, has fallen from everything!

Today instead of going to the field, I went to Google to look for mushrooms. Google has a tool called Google Trends . This tool lets you know what words people search through Google. A picture is worth a thousand words.

The first chart shows that the word "mushroom" has a strong seasonal component, with a peak search in the fall in the three years analyzed. But if we compare the years from 2006 the number of times you have searched for mushrooms in Google is much higher than in 2004 and 2005.

The graphic is even more dramatic if we look at second graph, a word "Boletus" one of the most prized mushrooms and has been especially good this year. It notes the same but more pronounced. The year 2006 was exceptional for the mushrooms. Raise your finger or the mouse who has beaten his record of taking mushrooms this year!

Funny how many people have not only left the field mushrooms in Spain this year, but many people have left the mushrooms for Google to come home with baskets full.

High Fever Cause Of Gums Wound?

A good year for mushrooms ... at Google



The increase in living standards, and even increased leisure time available, it makes more and more families go into the field to perform the salutary work of collecting mushrooms. not the same for a walk in the field without a definite goal, to go with the firm intention of looking for mushrooms, because mushrooms look brings the excitement built-in "seek and find." Any good fan will have been cuentade that this year has been excellent in mushrooms. Or rovellones chanterelles, porcini mushrooms, blue foot, Lepiotas, Amanita, Coprinus, agarose, has fallen from everything!

Today instead of going to the field, I went to Google to look for mushrooms. Google has a tool called Google Trends . This tool lets you know what words people search through Google. A picture is worth a thousand words.

The first chart shows that the word "mushroom" has a strong seasonal component, with a peak search in the fall in the three years analyzed. But if we compare the years from 2006 the number of times you have searched for mushrooms in Google is much higher than in 2004 and 2005.

The graphic is even more dramatic if we look at second graph, a word "Boletus" one of the most prized mushrooms and has been especially good this year. It notes the same but more pronounced. The year 2006 was exceptional for the mushrooms. Raise your finger or the mouse who has beaten his record of taking mushrooms this year!

Funny how many people have not only left the field mushrooms in Spain this year, but many people have left the mushrooms for Google to come home with baskets full.

Buttermilk Wafers Pancakes

From a strictly economic standpoint, would it be better for the rest of Spain that Catalonia was a nation?


Today I woke controversial. Or rather, I have awakened. I get an email about the transfer of VAT to Catalonia in the morning, with a data series that have made me think. Imagine you are a member of a family, say you're a brother, and one of your brothers steals the money to your parents, what are you doing? He would tell your parents, right? Well, something similar is what I am proposing today. I am an unusual person to discuss this, because the issue of nationalism seems to me old, boring, that does not awaken in me any kind of passion: I love Catalonia, I love Madrid, Valencia love, I would retire in Menorca sail around the Mediterranean Sea, which itself arouses my interest, and for that matter, I like to Cochin. So no politics. Let's ignore nationalism. Let's talk economics.

When purchasing any product from a company based on Catalonia, VAT is only for Catalonia. VAT transfer to Catalonia is one of the assignments that the government has made in Catalonia in the new statute. Whereas before it had 35%, now have 100%. This means that if you buy a car SEAT Galicia (based in Catalonia) VAT is only Catalonia, and taxes collected in Galicia have no impact on schools, hospitals, roads or anything in Galicia (or any other region of Spain). However, if the same person decides to buy a Ford (Ford headquarters in Madrid Spain and manufactured in Valencia), VAT is not going to Madrid or Valencia, is shared by all regions English and taxes collected in Galicia, Madrid and Valencia have an impact on schools and roads throughout the country. Or for example because the Catalan cava sold this Christmas, all the VAT impact only in Catalonia. While the tax collected by selling fine sherry is allocated to. Since then transfer the VAT to Catalonia, at least, uncooperative. It meant that in practice, will transfer money to poorer regions of the richest region of Spain, such as Catalonia.

The Catalans may argue that they have an entrepreneurial spirit, who have managed to create wealth and I would agree, actually. I am sensitive to those things and I admire him. The question I ask myself is, at this point, then would not it be better, from a strictly economic standpoint, for the rest of Spain, Catalonia was an independent country? And if not yet, are not we getting closer to that? Because VAT can be a lot of money, essentially has no limit ... Imagine, for example, Natural Gas (based in Catalonia) bought Endesa, the resulting company would have almost a monopoly of power in Spain. All VAT would be generated in Spain in Catalonia. However, if EON (German company) bought Endesa, VAT on electricity would be shared from Spain.
In such a situation would be more beneficial, for Spain, from the point of view, that Catalonia was a nation and not autonomy. For Catalans, ask yourself two questions is relevant, is that what they are trying to force, political independence? Or is it just money?
Finally, reflect a global vision. Because if you do Catalonia Valencia why not? "Galicia? Madrid? Does not this open the door we all want our money? But if we are not talking about politics. Biotek Why not independent? Indeed, I want the tax that generates my company Throughout Spain, is in my company, no schools for children of other bloggers as Alberto Noguera, TrackRecord, Fernan2 or Alfonso Ballesteros. Besides, I'm a molecular biologist who also speak a language no one understands. And I have I taken a look at some land in Menorca, with a pier and a house was to be a republic of the cutest ... Biotek independent!

Buttermilk Wafers Pancakes

From a strictly economic standpoint, would it be better for the rest of Spain that Catalonia was a nation?


Today I woke controversial. Or rather, I have awakened. I get an email about the transfer of VAT to Catalonia in the morning, with a data series that have made me think. Imagine you are a member of a family, say you're a brother, and one of your brothers steals the money to your parents, what are you doing? He would tell your parents, right? Well, something similar is what I am proposing today. I am an unusual person to discuss this, because the issue of nationalism seems to me old, boring, that does not awaken in me any kind of passion: I love Catalonia, I love Madrid, Valencia love, I would retire in Menorca sail around the Mediterranean Sea, which itself arouses my interest, and for that matter, I like to Cochin. So no politics. Let's ignore nationalism. Let's talk economics.

When purchasing any product from a company based on Catalonia, VAT is only for Catalonia. VAT transfer to Catalonia is one of the assignments that the government has made in Catalonia in the new statute. Whereas before it had 35%, now have 100%. This means that if you buy a car SEAT Galicia (based in Catalonia) VAT is only Catalonia, and taxes collected in Galicia have no impact on schools, hospitals, roads or anything in Galicia (or any other region of Spain). However, if the same person decides to buy a Ford (Ford headquarters in Madrid Spain and manufactured in Valencia), VAT is not going to Madrid or Valencia, is shared by all regions English and taxes collected in Galicia, Madrid and Valencia have an impact on schools and roads throughout the country. Or for example because the Catalan cava sold this Christmas, all the VAT impact only in Catalonia. While the tax collected by selling fine sherry is allocated to. Since then transfer the VAT to Catalonia, at least, uncooperative. It meant that in practice, will transfer money to poorer regions of the richest region of Spain, such as Catalonia.

The Catalans may argue that they have an entrepreneurial spirit, who have managed to create wealth and I would agree, actually. I am sensitive to those things and I admire him. The question I ask myself is, at this point, then would not it be better, from a strictly economic standpoint, for the rest of Spain, Catalonia was an independent country? And if not yet, are not we getting closer to that? Because VAT can be a lot of money, essentially has no limit ... Imagine, for example, Natural Gas (based in Catalonia) bought Endesa, the resulting company would have almost a monopoly of power in Spain. All VAT would be generated in Spain in Catalonia. However, if EON (German company) bought Endesa, VAT on electricity would be shared from Spain.
In such a situation would be more beneficial, for Spain, from the point of view, that Catalonia was a nation and not autonomy. For Catalans, ask yourself two questions is relevant, is that what they are trying to force, political independence? Or is it just money?
Finally, reflect a global vision. Because if you do Catalonia Valencia why not? "Galicia? Madrid? Does not this open the door we all want our money? But if we are not talking about politics. Biotek Why not independent? Indeed, I want the tax that generates my company Throughout Spain, is in my company, no schools for children of other bloggers as Alberto Noguera, TrackRecord, Fernan2 or Alfonso Ballesteros. Besides, I'm a molecular biologist who also speak a language no one understands. And I have I taken a look at some land in Menorca, with a pier and a house was to be a republic of the cutest ... Biotek independent!

The Perfect Bare Breast

The stock is for investors with little money, according to Warren Buffet.


I often hear my friends and family say that "the stock is for those who have much money." Or that "the little guy always loses." Well, I disagree, but I'm not alone, Warren Buffet agrees with me. Warren Buffet is considered by many the best investor (not speculator or trader) that has ever existed. A man who has achieved average annual gains of 30% for many years in a market usually runs from 7% to 11%. Well, Warren Buffet said the only condition necessary to win more than him, earn 50% per year is fewer than a million dollars invested in the stock market. That he would love to be a small investor to invest in small companies with little turnover and virtually unknown to the public, since these micro companies are more profitable for investors. In fact their argument is that the retail investor never should invest in large companies , because the only advantage over the large investor, calls "strong hands" is that big capital can not come by surprise in a small company without the market noticing, because the trading volume is so small that it would immediately raise the price of the stock and take a long time to take significant positions. The great opportunity of the small investor is to invest in small companies to large capital still have no access, and retain these shares as the company grows. Curious, no? Well now you and once you sell all your shares of IBEX-35 and I put to invest in microenterprises, that it is time to heed those who know. For a while Warren teaches his letters ... because you have seen the photo, not teach or luck, clear that Gates must have a care, because it must be a scary copiota ...

The Perfect Bare Breast

The stock is for investors with little money, according to Warren Buffet.


I often hear my friends and family say that "the stock is for those who have much money." Or that "the little guy always loses." Well, I disagree, but I'm not alone, Warren Buffet agrees with me. Warren Buffet is considered by many the best investor (not speculator or trader) that has ever existed. A man who has achieved average annual gains of 30% for many years in a market usually runs from 7% to 11%. Well, Warren Buffet said the only condition necessary to win more than him, earn 50% per year is fewer than a million dollars invested in the stock market. That he would love to be a small investor to invest in small companies with little turnover and virtually unknown to the public, since these micro companies are more profitable for investors. In fact their argument is that the retail investor never should invest in large companies , because the only advantage over the large investor, calls "strong hands" is that big capital can not come by surprise in a small company without the market noticing, because the trading volume is so small that it would immediately raise the price of the stock and take a long time to take significant positions. The great opportunity of the small investor is to invest in small companies to large capital still have no access, and retain these shares as the company grows. Curious, no? Well now you and once you sell all your shares of IBEX-35 and I put to invest in microenterprises, that it is time to heed those who know. For a while Warren teaches his letters ... because you have seen the photo, not teach or luck, clear that Gates must have a care, because it must be a scary copiota ...

Mastorbation Lube Ideas

The story of Viagra, the pharmaceutical industry, a business-to-face or cross

The pharmaceutical industry is characterized by a completely unpredictable business, in which a stroke of good fortune can tell success from failure. But worse is that the distance between success and failure in one product, it may mean to stop selling one billion euros! Each year! The story of the discovery of Viagra illustrates this so excellent, as is the story of a failure that became a business success unprecedented by a stroke of fate. Erectile dysfunction affects 10 percent of men. But that figure rose to 52 percent in men 40 to 70 years. Viagra is not the only but it was the first oral drug against impotence. Currently sold almost two billion euros per year, with profit margins approaching 90%. The story of the discovery is interesting because it illustrates how a stroke of luck could change the profits of an enterprise. is something that does not happen in any other business with this magnitude, with that sense of fate. Although of course you have to keep ready to identify opportunities.
all began in 1985 when Campbell and David Simon Roberts, both chemists at Pfizer, undertook the task of finding a compound of hypertension, discovering the sildenafil. Pfizer began clinical trials of phase I of sildenafil in healthy volunteers with no history of coronary heart disease, six years later, in July 1991. The following year, two things happened in parallel, changing the direction of research. Upon entering Phase II, the drug did not meet the expectations of the team in terms of activity in patients with severe coronary heart disease. However, during a study in which the dose was increased to the maximum, to see how drugs could be given to volunteers without incurring side effects, the volunteers showed side effects, including headache, indigestion, visual problems, muscle aches, and a change in erectile function. An interesting side effect ... For the team that discovered this change in erectile function was an interesting phenomenon. As the drug did not appear promising to treat patients with coronary disease, the team discussed the possibility of using sildenafil as a therapeutic drug against impotence. In May 1994, Pfizer began the first Phase II trial of sildenafil in men suffering from impotence. The rest is history. A business success story and pharmacist. Indeed, the active substance is white, blue is Marketing. If you have not tried it, is awesome, I assure you, I always I have some on hand just in case ;-).

Mastorbation Lube Ideas

The story of Viagra, the pharmaceutical industry, a business-to-face or cross

The pharmaceutical industry is characterized by a completely unpredictable business, in which a stroke of good fortune can tell success from failure. But worse is that the distance between success and failure in one product, it may mean to stop selling one billion euros! Each year! The story of the discovery of Viagra illustrates this so excellent, as is the story of a failure that became a business success unprecedented by a stroke of fate. Erectile dysfunction affects 10 percent of men. But that figure rose to 52 percent in men 40 to 70 years. Viagra is not the only but it was the first oral drug against impotence. Currently sold almost two billion euros per year, with profit margins approaching 90%. The story of the discovery is interesting because it illustrates how a stroke of luck could change the profits of an enterprise. is something that does not happen in any other business with this magnitude, with that sense of fate. Although of course you have to keep ready to identify opportunities.
all began in 1985 when Campbell and David Simon Roberts, both chemists at Pfizer, undertook the task of finding a compound of hypertension, discovering the sildenafil. Pfizer began clinical trials of phase I of sildenafil in healthy volunteers with no history of coronary heart disease, six years later, in July 1991. The following year, two things happened in parallel, changing the direction of research. Upon entering Phase II, the drug did not meet the expectations of the team in terms of activity in patients with severe coronary heart disease. However, during a study in which the dose was increased to the maximum, to see how drugs could be given to volunteers without incurring side effects, the volunteers showed side effects, including headache, indigestion, visual problems, muscle aches, and a change in erectile function. An interesting side effect ... For the team that discovered this change in erectile function was an interesting phenomenon. As the drug did not appear promising to treat patients with coronary disease, the team discussed the possibility of using sildenafil as a therapeutic drug against impotence. In May 1994, Pfizer began the first Phase II trial of sildenafil in men suffering from impotence. The rest is history. A business success story and pharmacist. Indeed, the active substance is white, blue is Marketing. If you have not tried it, is awesome, I assure you, I always I have some on hand just in case ;-).

Shoe Spray For Basketball Courts

If the height is just as bad bestow wealth, 50% of humans would measure 3.4 centimeters to 40 meters


In the previous post as we wondered would measure the wealthiest in an imaginary world in which the height would be partitioned in the same way that spreads the wealth on planet earth. And we came to the conclusion that 2% humans would measure more than 40 or 45 feet high, as a building about 12 floors, while the rest would measure about 86 centimeters, the same as a toddler. If this were a science fiction movie is not hard to imagine that these powerful giants have enslaved their tiny peers. But the data
World Institute for Development Economics Research of the United Nations University (World Institute for Development Economics of the United Nations University, UNU-WIDER ) may be even more chilling, because the poorest half of the world's adult population owned barely 1% of global wealth. If perform the same exercise, and try to visualize the distribution of wealth among the poor, how would measure the poorest in an imaginary world in which the height would be partitioned in the same way that spreads the wealth on earth? Figuring that the average height of human being is of 1.70 cm, 50% of the world's population would measure 3.4 centimeters!
No wonder that from Western countries, with that size, height of a blade of grass on a football field or golf or see them and the downtrodden as if they were why our lawn. Three thousand three hundred million people with a size of a few cm, blades of grass on the golf course of the very powerful.

fascinating planet, nightmare before christmas.
continued ...

Shoe Spray For Basketball Courts

If the height is just as bad bestow wealth, 50% of humans would measure 3.4 centimeters to 40 meters


In the previous post as we wondered would measure the wealthiest in an imaginary world in which the height would be partitioned in the same way that spreads the wealth on planet earth. And we came to the conclusion that 2% humans would measure more than 40 or 45 feet high, as a building about 12 floors, while the rest would measure about 86 centimeters, the same as a toddler. If this were a science fiction movie is not hard to imagine that these powerful giants have enslaved their tiny peers. But the data
World Institute for Development Economics Research of the United Nations University (World Institute for Development Economics of the United Nations University, UNU-WIDER ) may be even more chilling, because the poorest half of the world's adult population owned barely 1% of global wealth. If perform the same exercise, and try to visualize the distribution of wealth among the poor, how would measure the poorest in an imaginary world in which the height would be partitioned in the same way that spreads the wealth on earth? Figuring that the average height of human being is of 1.70 cm, 50% of the world's population would measure 3.4 centimeters!
No wonder that from Western countries, with that size, height of a blade of grass on a football field or golf or see them and the downtrodden as if they were why our lawn. Three thousand three hundred million people with a size of a few cm, blades of grass on the golf course of the very powerful.

fascinating planet, nightmare before christmas.
continued ...

How To Program Starchoice Remote To Tv

Millionaire: A Tale Financial Christmas. (First Party)


2% of the population owns 50% of the wealth. We've all heard or read of scary statistics like this, but I think few people really realize what these figures mean and how they explain the world in which we live. To try to give a graphic idea of \u200b\u200bthe extent to which this explains the planet we inhabit, I am going to make a comparison with the heights of people. Is my financial Christmas Carol.
In the world we live in is high and low, as there are rich and poor, right? One might think so, but the answer is no, that is not equal. The height is distributed according to a bell curve: On opposite ends are the world's tallest man a Chinese pastor of 55 years that measures just over 2.36 meters (see photo) and the man lowest in the world, Dominican actor Nelson de la Rosa, certified by the Guinness Book of Records as the world's smallest man, 54 inches tall. Between these two extremes we find the others. Often one tends to think intuitively that wealth is distributed in a similar way, people very rich and very poor among others. Let's see if it is true, what would happen in a world in which the height as it does bestow wealth on the planet Earth, if 2% of the population would hold 50% of the height available.
For this Christmas fable, imagine a world of 100 people where the average height is 1.70 meters. In a normal world would have the highest with 2.36 meters and the lowest of 54 centimeters, and in between everyone else. But in my world of Christmas fable, as in the distribution of wealth on Earth, two percent, or two people, a couple, own 50% of global stature. So, this couple, whom we shall call Pocero Pocero and because it is a story Christmas very English, own 50% of the overall height is 1.70 multiplied by 100 and 170 meters, divided by two, 85 feet. including two total of 85 meters, leaving to the other 98 people in Pocerolandia another 85 meters. This means that Pocero, which is a little taller than his wife, is 45 meters and women's 40 meters. The rest of the people measured an average of 85 meters between 98 people, or 86 centimeters. Well, now try to imagine what that means for the distribution of power on Earth. To give you an idea, 40 or 45 meters is the size of a building 10 or 12 floors. Imagine that in this world of fable ye had a problem with the power and you must fight vieseis against him. Or simply wanted to "grow" and unwilling Pocero. The fight would be similar to that of a toddler, an average height of 86 cm , against a 12-story building! If it is difficult for a toddler to his father, 170 cm, how will the distribution of power in the land if the fight is between children from 2 years against giants as tall as 12 storey buildings? Obviously, Pocerolandia, these giants of over 40 meters are known all together and it is not difficult to imagine that they have totally enslaved to the poor pygmies of 86 centimeters. Soon Pocerolandia tell you more stories, but let me end with a reflection:

If you think a moment in this view, theories slavery as Bilderberg club that I always seemed rather paranoid, does not seem far less paranoid? Ummmm ... Perhaps only more difficult to prove, because the wealth is not as inescapable as height and these giants are not stupid ... Pocerolandia exciting world ...

continued ...

How To Program Starchoice Remote To Tv

Millionaire: A Tale Financial Christmas. (First Party)


2% of the population owns 50% of the wealth. We've all heard or read of scary statistics like this, but I think few people really realize what these figures mean and how they explain the world in which we live. To try to give a graphic idea of \u200b\u200bthe extent to which this explains the planet we inhabit, I am going to make a comparison with the heights of people. Is my financial Christmas Carol.
In the world we live in is high and low, as there are rich and poor, right? One might think so, but the answer is no, that is not equal. The height is distributed according to a bell curve: On opposite ends are the world's tallest man a Chinese pastor of 55 years that measures just over 2.36 meters (see photo) and the man lowest in the world, Dominican actor Nelson de la Rosa, certified by the Guinness Book of Records as the world's smallest man, 54 inches tall. Between these two extremes we find the others. Often one tends to think intuitively that wealth is distributed in a similar way, people very rich and very poor among others. Let's see if it is true, what would happen in a world in which the height as it does bestow wealth on the planet Earth, if 2% of the population would hold 50% of the height available.
For this Christmas fable, imagine a world of 100 people where the average height is 1.70 meters. In a normal world would have the highest with 2.36 meters and the lowest of 54 centimeters, and in between everyone else. But in my world of Christmas fable, as in the distribution of wealth on Earth, two percent, or two people, a couple, own 50% of global stature. So, this couple, whom we shall call Pocero Pocero and because it is a story Christmas very English, own 50% of the overall height is 1.70 multiplied by 100 and 170 meters, divided by two, 85 feet. including two total of 85 meters, leaving to the other 98 people in Pocerolandia another 85 meters. This means that Pocero, which is a little taller than his wife, is 45 meters and women's 40 meters. The rest of the people measured an average of 85 meters between 98 people, or 86 centimeters. Well, now try to imagine what that means for the distribution of power on Earth. To give you an idea, 40 or 45 meters is the size of a building 10 or 12 floors. Imagine that in this world of fable ye had a problem with the power and you must fight vieseis against him. Or simply wanted to "grow" and unwilling Pocero. The fight would be similar to that of a toddler, an average height of 86 cm , against a 12-story building! If it is difficult for a toddler to his father, 170 cm, how will the distribution of power in the land if the fight is between children from 2 years against giants as tall as 12 storey buildings? Obviously, Pocerolandia, these giants of over 40 meters are known all together and it is not difficult to imagine that they have totally enslaved to the poor pygmies of 86 centimeters. Soon Pocerolandia tell you more stories, but let me end with a reflection:

If you think a moment in this view, theories slavery as Bilderberg club that I always seemed rather paranoid, does not seem far less paranoid? Ummmm ... Perhaps only more difficult to prove, because the wealth is not as inescapable as height and these giants are not stupid ... Pocerolandia exciting world ...

continued ...

When Huntik Season 2 Begin?

George Soros is invested in biotechnology, although it does express some of their profits


As we said recently strong hands were invested in biotechnology , an extreme example of this is George Soros.
George Soros is for many the archetype of the speculator and prophet of "post-capitalism." Is American, although born in Budapest. Today is one of the richest men in the world but has been emigrant painter and porterage. As head of various "cracks in the stock market", while patrons in about fifty countries through grants to human rights organizations, scholarships for black students in South Africa and support for various social projects in Eastern Europe , is flattered and feared at the same time. It currently has a fortune estimated at 7 billion dollars, but manages many billions more dollars in markets worldwide, and their movements Money is capable of changing the destiny of a country, a currency or an industry.
In June this year, Soros had invested in biotechnology and pharmaceutical companies 49% of their funds. An outrage to everyone, but much more for a financial speculator not particularly versed in the field. For example, in telecommunications was only slightly less than 3% and the second sector in which he invested was more consumer services (which are included supermarkets, media, leisure and travel agencies and tourism and leisure) a sector was exposed in just under 19%. But today has been known that, throughout the summer Soros had sold a large part of their biotechnological reducing their exposure to 25.2%. Biotechnology still remains the sector in which has a greater exposure, especially biotechnology and pharmaceutical companies American, recently commented that as well are our favorites, even ahead of the telecommunications, oil (7%) or consumer services, where their exposure is still below 25%.
obviously has taken a good return on their bios, because as we said before the AMEX biotech has risen sharply this year that could or . A good collection of benefits and remains heavily exposed to the sector.

When Huntik Season 2 Begin?

George Soros is invested in biotechnology, although it does express some of their profits


As we said recently strong hands were invested in biotechnology , an extreme example of this is George Soros.
George Soros is for many the archetype of the speculator and prophet of "post-capitalism." Is American, although born in Budapest. Today is one of the richest men in the world but has been emigrant painter and porterage. As head of various "cracks in the stock market", while patrons in about fifty countries through grants to human rights organizations, scholarships for black students in South Africa and support for various social projects in Eastern Europe , is flattered and feared at the same time. It currently has a fortune estimated at 7 billion dollars, but manages many billions more dollars in markets worldwide, and their movements Money is capable of changing the destiny of a country, a currency or an industry.
In June this year, Soros had invested in biotechnology and pharmaceutical companies 49% of their funds. An outrage to everyone, but much more for a financial speculator not particularly versed in the field. For example, in telecommunications was only slightly less than 3% and the second sector in which he invested was more consumer services (which are included supermarkets, media, leisure and travel agencies and tourism and leisure) a sector was exposed in just under 19%. But today has been known that, throughout the summer Soros had sold a large part of their biotechnological reducing their exposure to 25.2%. Biotechnology still remains the sector in which has a greater exposure, especially biotechnology and pharmaceutical companies American, recently commented that as well are our favorites, even ahead of the telecommunications, oil (7%) or consumer services, where their exposure is still below 25%.
obviously has taken a good return on their bios, because as we said before the AMEX biotech has risen sharply this year that could or . A good collection of benefits and remains heavily exposed to the sector.

Panera Bread Hazelnut Coffee

Picking on a boat in Venice or a guide map for Biotechs buy American.



If you've seen Casino Royale, the latest James Bond film, a number of scenes in which Bond and his girl make a romantic trip on a private boat along the canals of Venice. As one of my great passions is sailing, I wondered if he could "emulate Bond" and if anyone can walk in sailing through the canals of Venice. Well, no. Prohibited from doing so and is the typical thing that only happens in movies. For starters, because the bridges are too low to drive a boat (in the photos you can see that the mast had to dismount to push the boat in the channel), but while the mast was small enough to pass, would still be banned by the Italian government.

There are many investors who are so with biotechnology, do not invest in it because it is a difficult world to understand. The manipulation of genes, DNA, RNA, stem cells, RNA interference or gene therapy. These are complicated concepts, but rather for specialists, why bother to understand how easy it is to buy an apartment or buy shares in the electrical business that is easier to understand? Moreover, most biotechnology companies listed on foreign markets. As previously ahead, American companies account for more patents interesting, which makes it even harder to know, for their developments and progress do not appear in the English media and the information is not readily accessible, is in English.

For now, faced with the choice to put me to explain these things or take a shortcut, I decided to take a risky shortcut: dump here my portfolio and see how they do. The choice I can repeat, but this is not a recommendation to buy or sell. The intention is that it serves as a roadmap in the world of biotechnology. Go up or down according to those who read me you can assess whether deserved (and deserves) getting off a boat in the canals of Venice, it is worth investing in a biotechnology company, or if we leave the world of fantasy. This is my portfolio today:

NASDAQ 9,741 U.S. DOLLARS 0.000 NASDAQ Alnylam Pharmaceuticals Inc. 2,001 U.S. DOLLARS

NEW YORK	Celera Genomics	64	880.000 U.S. DOLLARS		11/27/2006 16:01:00
	LEXIcom GENETIC		37015.800		11/27/2006 16:04:00
NASDAQ	Incyte Genomics Inc.	0			27/11/2006 U.S. DOLLARS 16:05:00
NASDAQ	ArQule Inc.		2596.770 549 U.S. DOLLARS		11/27/2006 16:07:00
			40620.300		11/27/2006 16:07:00
NASDAQ	Exelixis Inc.		523 4550, 100 U.S. DOLLARS		11/27/2006 16:08:00

As you can I have now seen a portfolio of six shares, one listed in New York and the other five listed on the Nasdaq. But every action has a very variable in my portfolio. From actions such as Alnylam, which is worth about 40mil today dollars, up actions such as Celera, whose value is now below $ 1000. All these actions have in common that, in my opinion, have the potential to multiply its value, and therefore the value of our investment, by 10 within 5 years. What venture capitalists Americans call a potential 10x/5y , 10veces in 5 years (years). I promise to tell more about these actions and their awesome potential. But also on the risks of investing in these companies ...

Panera Bread Hazelnut Coffee

Picking on a boat in Venice or a guide map for Biotechs buy American.



If you've seen Casino Royale, the latest James Bond film, a number of scenes in which Bond and his girl make a romantic trip on a private boat along the canals of Venice. As one of my great passions is sailing, I wondered if he could "emulate Bond" and if anyone can walk in sailing through the canals of Venice. Well, no. Prohibited from doing so and is the typical thing that only happens in movies. For starters, because the bridges are too low to drive a boat (in the photos you can see that the mast had to dismount to push the boat in the channel), but while the mast was small enough to pass, would still be banned by the Italian government.

There are many investors who are so with biotechnology, do not invest in it because it is a difficult world to understand. The manipulation of genes, DNA, RNA, stem cells, RNA interference or gene therapy. These are complicated concepts, but rather for specialists, why bother to understand how easy it is to buy an apartment or buy shares in the electrical business that is easier to understand? Moreover, most biotechnology companies listed on foreign markets. As previously ahead, American companies account for more patents interesting, which makes it even harder to know, for their developments and progress do not appear in the English media and the information is not readily accessible, is in English.

For now, faced with the choice to put me to explain these things or take a shortcut, I decided to take a risky shortcut: dump here my portfolio and see how they do. The choice I can repeat, but this is not a recommendation to buy or sell. The intention is that it serves as a roadmap in the world of biotechnology. Go up or down according to those who read me you can assess whether deserved (and deserves) getting off a boat in the canals of Venice, it is worth investing in a biotechnology company, or if we leave the world of fantasy. This is my portfolio today:

NASDAQ 9,741 U.S. DOLLARS 0.000 NASDAQ Alnylam Pharmaceuticals Inc. 2,001 U.S. DOLLARS

NEW YORK	Celera Genomics	64	880.000 U.S. DOLLARS		11/27/2006 16:01:00
	LEXIcom GENETIC		37015.800		11/27/2006 16:04:00
NASDAQ	Incyte Genomics Inc.	0			27/11/2006 U.S. DOLLARS 16:05:00
NASDAQ	ArQule Inc.		2596.770 549 U.S. DOLLARS		11/27/2006 16:07:00
			40620.300		11/27/2006 16:07:00
NASDAQ	Exelixis Inc.		523 4550, 100 U.S. DOLLARS		11/27/2006 16:08:00

As you can I have now seen a portfolio of six shares, one listed in New York and the other five listed on the Nasdaq. But every action has a very variable in my portfolio. From actions such as Alnylam, which is worth about 40mil today dollars, up actions such as Celera, whose value is now below $ 1000. All these actions have in common that, in my opinion, have the potential to multiply its value, and therefore the value of our investment, by 10 within 5 years. What venture capitalists Americans call a potential 10x/5y , 10veces in 5 years (years). I promise to tell more about these actions and their awesome potential. But also on the risks of investing in these companies ...

Checkered Metal Cores

strong hands are always ahead: The wealthy take positions in biotechnology.

All
economic growth cycle has stages. If the industry is not new, as with biotechnology, usually comes from a long trek through the desert where nobody wants or hear about investing in it. In the case of changes, come from the phase of euphoria in 2000, when the announcement of the human genome sequence shot contributions biotechnology companies worldwide. In Spain we had our particular local mini-episode Zeltia. That turned into a bubble, with stratospheric valuations for an industry which still had many years to be really competitive. Experts begin selling and went into a tragic phase. Many lost a lot of money around the world. Biotechnology lost interest. In Spain, many were left with Zeltia and / or Puleva Biotech worth 30% to 60% less than it was worth. And years went by without recovery. The people, the weak hands, swore never to invest in bios. But things are changing. The reasons why those companies achieved huge market prices remain, some have already commented in the previous post: The boom in the elderly: an investment opportunity?

In these seven years, industry has also matured and business prospects are improving. The first sign of this change in perception is that strong hands are taking positions, the great fortunes begin to see the sector differently. For example, BBVA wealth manager, a unit aimed at customers with more than two billion euros of assets, said in an interview that they are already preparing to take positions biotechnology . Strong hands are always ahead.

The second sign of change, is that prices start to rise. The Amex biotech index has risen this year, so far, 15.3%, four percentage points higher than the S & P500. Some companies, like those who work in RNA interference technology, technology that has won the Nobel Prize for Medicine this year have risen by 321%, and Sirna Therapeutics and Alnylam Pharmaceuticals, more than 50%. Yet this increase is hardly noticed. Still have not even caught our biotechnological Zeltia, for example, loses this year, more than three percentage points, and that in a great year for stocks. This can mean two things: one, that the English business cycle is delayed by about 9 months with the U.S. cycle and the infection will come next year. Two, that the English biotechnology has lost the car of progress and that no Biotechs can be invested in Spain because the companies that have garnered the most valuable patents are in the United States. My opinion? There is something of both, but that we'll talk later, if no chance ...

Checkered Metal Cores

strong hands are always ahead: The wealthy take positions in biotechnology.

All
economic growth cycle has stages. If the industry is not new, as with biotechnology, usually comes from a long trek through the desert where nobody wants or hear about investing in it. In the case of changes, come from the phase of euphoria in 2000, when the announcement of the human genome sequence shot contributions biotechnology companies worldwide. In Spain we had our particular local mini-episode Zeltia. That turned into a bubble, with stratospheric valuations for an industry which still had many years to be really competitive. Experts begin selling and went into a tragic phase. Many lost a lot of money around the world. Biotechnology lost interest. In Spain, many were left with Zeltia and / or Puleva Biotech worth 30% to 60% less than it was worth. And years went by without recovery. The people, the weak hands, swore never to invest in bios. But things are changing. The reasons why those companies achieved huge market prices remain, some have already commented in the previous post: The boom in the elderly: an investment opportunity?

In these seven years, industry has also matured and business prospects are improving. The first sign of this change in perception is that strong hands are taking positions, the great fortunes begin to see the sector differently. For example, BBVA wealth manager, a unit aimed at customers with more than two billion euros of assets, said in an interview that they are already preparing to take positions biotechnology . Strong hands are always ahead.

The second sign of change, is that prices start to rise. The Amex biotech index has risen this year, so far, 15.3%, four percentage points higher than the S & P500. Some companies, like those who work in RNA interference technology, technology that has won the Nobel Prize for Medicine this year have risen by 321%, and Sirna Therapeutics and Alnylam Pharmaceuticals, more than 50%. Yet this increase is hardly noticed. Still have not even caught our biotechnological Zeltia, for example, loses this year, more than three percentage points, and that in a great year for stocks. This can mean two things: one, that the English business cycle is delayed by about 9 months with the U.S. cycle and the infection will come next year. Two, that the English biotechnology has lost the car of progress and that no Biotechs can be invested in Spain because the companies that have garnered the most valuable patents are in the United States. My opinion? There is something of both, but that we'll talk later, if no chance ...